← Back to patent-cliff list
CAS 150374-97-3
benzyl (2-aminobenzoyl)glycinate
Codes: SIVE-004
Application context (from source-drug indications)
Acute lung injurySivelestat Sodium Hydrate全身炎症反应综合征Sivelestat Sodium Hydrate视神经脊髓炎Sivelestat Sodium Hydrate感染性休克Sivelestat Sodium Hydrate血液凝固障碍Sivelestat Sodium HydrateCoronary artery lesionSivelestat Sodium Hydrate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Sivelestat Sodium Hydrate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2-nitrobenzoyl chloride→benzyl glycinate 4-methylbenzenesulfonate→benzyl (2-nitrobenzoyl)glycinate→benzyl (2-aminobenzoyl)glycinate→4-(chlorosulfonyl)phenyl pivalate→4-(N-(2-((2-(benzyloxy)-2-oxoethyl)carbamoyl)phenyl)sulfamoyl)phenyl pivalate→(2-((4-(pivaloyloxy)phenyl)sulfonamido)benzoyl)glycine→4-hydroxybenzenesulfonic acid→pivaloyl chloride→sodium 4-(pivaloyloxy)benzenesulfonate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.